Cadila Healthcare Ltd.

NSE: CADILAHC | BSE: 532321 | ISIN: INE010B01027 |Industry: Pharmaceuticals
|Expensive Performer

Cadila Healthcare Ltd.    
15 Mar 2019
Geojit BNP Paribas
Robust US sales; high debt remains a concern Cadila Healthcare (Cadila) is India's leading vertically integrated pharmaceutical company. With its presence across the value chain, it manufactures finished dosage forms, active pharmaceutical...
Geojit BNP Paribas downgraded Cadila Healthcare Ltd. to Hold with a price target of 358.0 on 15 Mar, 2019.
More from Cadila Healthcare Ltd.